Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Abstract Triple-negative breast cancer (TNBC) is classically defined by estrogen receptor (ER) and progesterone receptor (PR) immunohistochemistry expression <1% and absence of HER2 amplification/overexpression. HER2-negative breast cancer with low ER/PR expression (1–10%) has a gene expression prof...

全面介紹

書目詳細資料

Principais autores:	Rachel Yoder, Bruce F. Kimler, Joshua M. Staley, Kelsey Schwensen, Yen Y. Wang, Karissa Finke, Anne O’Dea, Lauren Nye, Manana Elia, Gregory Crane, Richard McKittrick, Robert Pluenneke, Sheshadri Madhusudhana, Larry Beck, Anuj Shrestha, Larry Corum, Mark Marsico, Shane R. Stecklein, Andrew K. Godwin, Qamar J. Khan, Priyanka Sharma
格式:	Artigo
語言:	Inglês
出版:	Nature Portfolio 2022-07-01
叢編:	npj Breast Cancer
在線閱讀:	https://doi.org/10.1038/s41523-022-00448-4
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!